Cannara Biotech Inc. (TSXV:LOVE)
Canada · Delayed Price · Currency is CAD 1.900
-0.050 (-2.56%)
Aug 8, 2025, 3:59 PM EDT
Accolade Market Cap
Cannara Biotech has a market cap or net worth of CAD 173.72 million as of August 8, 2025. Its market cap has increased by 188.04% in one year.
Market Cap
173.72M
Enterprise Value
206.79M
Revenue
101.87M
Ranking
n/a
PE Ratio
11.19
Stock Price
$1.90
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 173.72M, a decrease of -17.91%. That is a compound annual growth rate of -2.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 173.72M | 160.79% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | 59.03M | -33.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.20B |
| Curaleaf Holdings | 1.77B |
| Sienna Senior Living | 1.71B |
| dentalcorp Holdings | 1.63B |
| Trulieve Cannabis | 1.41B |
| WELL Health Technologies | 1.20B |
| Cronos Group | 1.11B |
| Extendicare | 1.06B |